The susceptibility of aerobic and anaerobic bacteria, L-phase variants, candida, protozoa and viruses to lysolecithin.
D000256:Adenoviridae; D000818:Animals; D001419:Bacteria / Q000187:drug effects*; D002175:Candida; D002176:Candida albicans / Q000187:drug effects; D004748:Entamoeba histolytica / Q000187:drug effects; D056890:Eukaryota; D007740:L Forms; D008244:Lysophosphatidylcholines / Q000494:pharmacology*; D009975:Orthomyxoviridae; D011513:Proteus mirabilis; D012229:Rhinovirus; D018139:Simplexvirus; D013210:Staphylococcus; D013297:Streptococcus pyogenes
D008244:Lysophosphatidylcholines